Vir Biotechnology (VIR) Depreciation and Depletion (2023 - 2026)

Vir Biotechnology (VIR) has 4 years of Depreciation and Depletion data on file, last reported at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion fell 3.57% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $11.3 million (down 10.32% YoY), and the FY2025 full-year result was $11.4 million, down 19.72% from the prior year.
• Depreciation and Depletion eased to $2.7 million in Q1 2026, from $2.8 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $5.5 million in Q1 2023 to a low of $2.7 million in Q4 2024.
• A 4-year average of $3.6 million and a median of $2.9 million in 2024 frame the typical range for Depreciation and Depletion.
• Across the five-year window, Depreciation and Depletion plunged 37.21% in 2024 and advanced 3.7% in 2025, its largest moves.
• Tracing VIR's Depreciation and Depletion over 4 years: stood at $4.3 million in 2023, then sank by 37.21% to $2.7 million in 2024, then increased by 3.7% to $2.8 million in 2025, then retreated by 3.57% to $2.7 million in 2026.
• Business Quant data shows VIR's Depreciation and Depletion at $2.7 million in Q1 2026, $2.8 million in Q4 2025, and $2.9 million in Q3 2025.